HK1019339A1 - Antibodies against interferon alpha/beta receptor. - Google Patents

Antibodies against interferon alpha/beta receptor.

Info

Publication number: HK1019339A1
Authority: HK; Hong Kong
Prior art keywords: antibodies against; interferon alpha; beta receptor; against interferon; receptor
Prior art date: 1996-05-01

Application number

HK99104252A

Other languages

English (en)

Inventor

Daniela Novick

Menachem Rubinstein

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-01

Filing date

1999-09-30

Publication date

2000-02-03

1999-09-30 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2000-02-03 Publication of HK1019339A1 publication Critical patent/HK1019339A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Mycology (AREA)
Diabetes (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Epidemiology (AREA)
Food Science & Technology (AREA)
Obesity (AREA)
Plant Pathology (AREA)

HK99104252A 1996-05-01 1999-09-30 Antibodies against interferon alpha/beta receptor. HK1019339A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL11809696A IL118096A0 (en)	1996-05-01	1996-05-01	Antibodies against interferon alpha/beta receptor
PCT/IL1997/000138 WO1997041229A1 (en)	1996-05-01	1997-04-29	Antibodies against interferon alpha/beta receptor

Publications (1)

Publication Number	Publication Date
HK1019339A1 true HK1019339A1 (en)	2000-02-03

Family

ID=11068814

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK99104252A HK1019339A1 (en)	1996-05-01	1999-09-30	Antibodies against interferon alpha/beta receptor.

Country Status (19)

Country	Link
US (1)	US6136309A (uk)
EP (2)	EP1739177A1 (uk)
JP (1)	JP4308322B2 (uk)
KR (2)	KR100581798B1 (uk)
CN (1)	CN1198929C (uk)
AT (1)	ATE342981T1 (uk)
AU (1)	AU719995B2 (uk)
BR (1)	BR9709202A (uk)
CA (1)	CA2253239C (uk)
DE (1)	DE69736835T2 (uk)
DK (1)	DK0927252T3 (uk)
EA (1)	EA002543B1 (uk)
ES (1)	ES2274542T3 (uk)
HK (1)	HK1019339A1 (uk)
IL (2)	IL118096A0 (uk)
NO (1)	NO324206B1 (uk)
PT (1)	PT927252E (uk)
UA (1)	UA76396C2 (uk)
WO (1)	WO1997041229A1 (uk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0563487A1 (en) *	1992-03-31	1993-10-06	Laboratoire Europeen De Biotechnologie S.A.	Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US6713609B1 (en)	1996-07-16	2004-03-30	Genentech, Inc.	Monoclonal antibodies to type I interferon receptor
US6376067B1 (en) *	1998-12-21	2002-04-23	Mitsubishi Polyester Film, Llc	Silicone coated film with back side slip control coating and method of controlling slip of such film
RU2181297C2 (ru)	2000-06-20	2002-04-20	Эпштейн Олег Ильич	Способ лечения патологического синдрома и лекарственное средство
ATE502648T1 (de) *	2001-01-09	2011-04-15	Baylor Res Inst	Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
AU2007202840B2 (en) *	2001-01-09	2011-07-28	Baylor Research Institute	Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
US7087726B2 (en)	2001-02-22	2006-08-08	Genentech, Inc.	Anti-interferon-α antibodies
UA76640C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76638C2 (en) *	2002-08-02	2006-08-15	Oleh Illich Epshtein	Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
WO2004093908A2 (en) *	2003-04-23	2004-11-04	Medarex, Inc.	Compositions and methods for the therapy of inflammatory bowel disease
AU2007203559B2 (en) *	2003-04-23	2010-09-02	E. R. Squibb & Sons, L.L.C.	Compositions and methods for the therapy of inflammatory bowel disease
LT2418220T (lt)	2003-12-10	2017-10-10	E. R. Squibb & Sons, L.L.C.	Interferono-alfa antikūnai ir jų panaudojimas
EP1781705B1 (en) *	2004-06-21	2014-10-08	Medarex, L.L.C.	Interferon alpha receptor i antibodies and their uses
JP5837730B2 (ja)	2005-02-10	2015-12-24	ベイラーリサーチインスティテュートＢａｙｌｏｒＲｅｓｅａｒｃｈＩｎｓｔｉｔｕｔｅ	抗インターフェロンアルファモノクローナル抗体及び使用方法
US7888481B2 (en) *	2005-02-10	2011-02-15	Baylor Research Institute	Anti-interferon alpha monoclonal antibodies and methods for use
JP2008543335A (ja) *	2005-06-22	2008-12-04	ジェネンテック・インコーポレーテッド	Ｉｆｎａｒ２を標的とするための方法と組成物
AU2009245792B2 (en) *	2008-05-07	2012-11-01	Coimmune, Inc.	Humanized antibodies against human interferon-alpha
FR2962651A1 (fr)	2010-07-15	2012-01-20	Oleg Iliich Epshtein	Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections fonctionnelles du tractus gastro-intestinal
FR2962656A1 (fr)	2010-07-15	2012-01-20	Oleg Iliich Epshtein	Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps
WO2018010140A1 (zh) *	2016-07-14	2018-01-18	中国科学院生物物理研究所	I型干扰素受体抗体及其用途
CN115558027B (zh) *	2022-12-05	2023-02-28	北京万泰生物药业股份有限公司	一种核酸酶的单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0563487A1 (en) *	1992-03-31	1993-10-06	Laboratoire Europeen De Biotechnologie S.A.	Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
IL108584A (en) *	1994-02-07	2008-03-20	Yeda Res & Dev	Cloning of the interferon-binding protein ALPHA / BETA
IL106591A (en) *	1992-09-03	2008-03-20	Yeda Res & Dev	Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
JPH11501283A (ja) *	1993-09-17	1999-02-02	ラボラトワールウーロペアンドゥバイオテクノロジソシエテアノニム	Ｉ型インターフェロンに対する中和活性を有する、インターフェロンレセプターに対するモノクローナル抗体を含んでなる医薬組成物

1996
- 1996-05-01 IL IL11809696A patent/IL118096A0/xx unknown
1997
- 1997-04-29 JP JP53837897A patent/JP4308322B2/ja not_active Expired - Lifetime
- 1997-04-29 BR BR9709202A patent/BR9709202A/pt active Search and Examination
- 1997-04-29 EP EP06014510A patent/EP1739177A1/en not_active Withdrawn
- 1997-04-29 DE DE69736835T patent/DE69736835T2/de not_active Expired - Lifetime
- 1997-04-29 WO PCT/IL1997/000138 patent/WO1997041229A1/en active IP Right Grant
- 1997-04-29 PT PT97919622T patent/PT927252E/pt unknown
- 1997-04-29 KR KR1020047011388A patent/KR100581798B1/ko not_active IP Right Cessation
- 1997-04-29 AU AU24027/97A patent/AU719995B2/en not_active Expired
- 1997-04-29 EA EA199800968A patent/EA002543B1/ru not_active IP Right Cessation
- 1997-04-29 DK DK97919622T patent/DK0927252T3/da active
- 1997-04-29 CN CNB971951861A patent/CN1198929C/zh not_active Expired - Lifetime
- 1997-04-29 EP EP97919622A patent/EP0927252B1/en not_active Expired - Lifetime
- 1997-04-29 IL IL126835A patent/IL126835A/en not_active IP Right Cessation
- 1997-04-29 CA CA2253239A patent/CA2253239C/en not_active Expired - Lifetime
- 1997-04-29 ES ES97919622T patent/ES2274542T3/es not_active Expired - Lifetime
- 1997-04-29 UA UA98116315A patent/UA76396C2/uk unknown
- 1997-04-29 AT AT97919622T patent/ATE342981T1/de active
- 1997-04-29 KR KR1019980708393A patent/KR20000064953A/ko active Search and Examination
1998
- 1998-04-29 US US09/171,979 patent/US6136309A/en not_active Expired - Lifetime
- 1998-10-29 NO NO19985050A patent/NO324206B1/no not_active IP Right Cessation
1999
- 1999-09-30 HK HK99104252A patent/HK1019339A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR9709202A (pt)	1999-08-10
DE69736835T2 (de)	2007-11-22
EA199800968A1 (ru)	1999-04-29
IL126835A (en)	2007-07-24
IL118096A0 (en)	1996-09-12
DK0927252T3 (da)	2007-02-05
EA002543B1 (ru)	2002-06-27
CN1198929C (zh)	2005-04-27
KR20000064953A (ko)	2000-11-06
JP4308322B2 (ja)	2009-08-05
ATE342981T1 (de)	2006-11-15
EP0927252B1 (en)	2006-10-18
DE69736835D1 (de)	2006-11-30
US6136309A (en)	2000-10-24
AU719995B2 (en)	2000-05-18
CA2253239A1 (en)	1997-11-06
PT927252E (pt)	2007-01-31
KR100581798B1 (ko)	2006-05-25
WO1997041229A1 (en)	1997-11-06
ES2274542T3 (es)	2007-05-16
EP1739177A1 (en)	2007-01-03
KR20040075105A (ko)	2004-08-26
AU2402797A (en)	1997-11-19
JP2000509276A (ja)	2000-07-25
CA2253239C (en)	2010-08-10
EP0927252A1 (en)	1999-07-07
NO985050D0 (no)	1998-10-29
UA76396C2 (en)	2006-08-15
NO985050L (no)	1998-12-29
CN1220699A (zh)	1999-06-23
NO324206B1 (no)	2007-09-10

Legal Events

Date	Code	Title	Description
2005-08-19	CHRG	Changes in the register	Free format text: CORRECTION OF THE NAME OF THE INVENTOR FROM MENACHEM RUBINSTEN TO MENACHEM RUBINSTEIN
2017-05-12	PE	Patent expired	Effective date: 20170428

Publication	Publication Date	Title
IL118096A0 (en)	1996-09-12	Antibodies against interferon alpha/beta receptor
EP0671417A3 (en)	1995-11-22	Components and catalysts for the polymerization of olefins.
ZA981467B (en)	1999-08-23	Catalyst composition.
HK1031895A1 (en)	2001-06-29	Chimeric interleukin-6 soluble receptor/ligand protein and uses thereof.
ZA926962B (en)	1993-04-13	Chimaeric interleukin 5-recptor/immunoglobulin polypeptides.
ZA981340B (en)	1999-08-10	High activity polyethylene catalysts.
WO1998057983A3 (en)	1999-03-18	Mammalian neuro-growth factor like protein
ZA9811070B (en)	2000-07-03	Type I interferons.
EP0896002A4 (en)	2005-02-02	CHIMERIC PROTEINS, THEIR HETERODIMER COMPLEXES AND BLOOD PLATE REPLACEMENT
FR2718120B1 (fr)	1996-06-14	Quai de chargement intégré, autonome.
EP0588036A3 (en)	1995-04-19	Composition for isolating apamine receptors, apamine binding protein and their uses.
ZA986160B (en)	2000-01-10	2,4,4-trisubstituted-1,3-dioxolone antifungals.
DE69101290T2 (de)	1994-06-09	Neigbares Fahrzeug.
ES1038575Y (es)	1999-01-01	Mesa perfeccionada.
MX9101412A (es)	1992-06-05	Activadores mezclados para catalizadores por metatesis,estabilizados
ES1017699Y (es)	1992-07-01	Plataforma ligera de carga, perfeccionada.
ES1037062Y (es)	1998-05-01	Mesa de mezclas perfeccionada.
ES1033644Y (es)	1997-03-01	Mesa perfeccionada.
ES1029453Y (es)	1995-10-16	Conjunto de archivo automontable.
EP0589612A3 (en)	1995-04-19	Label trapping bond test, non-separation.
ZA969260B (en)	1998-07-29	Skip.
ES1021057Y (es)	1993-03-16	Encendedor perfeccionado.
ES1033248Y (es)	1997-01-16	Conjunto modular de mesa convertible.
ZA977109B (en)	1998-05-11	Iron regulated promoter and uses thereof.
ES1033388Y (es)	1997-01-01	Juego de mesa perfeccionado.